InSiGHt Health Clinical Ltd

InSiGHt Health Clinical Ltd

About Us

InSiGHt Health Clinical Ltd is a clinical service firm and Contract Research Organization (CRO) committed to delivering high-quality clinical services and research. We work with emerging to mid-sized companies to provide solutions in the clinical operations process by ensuring quality services, integrity, and the highest possible standards. Our services include product registrations and market entry processes, clinical research management, monitoring and site management, data management, clinical site assessment and set-up, and general project management.

At InSiGHt Health Clinical, we collaboratively support your product development and understand the importance of your innovations. Our strength lies in understanding our clients' vision for their products and clinical services,strategising and applying technically sound and efficient processes within the Good Clinical Practices (GCP) framework to achieve their goals.

Clinical Monitoring and Site Management

Site Identification and Feasibility Studies
Pre-study visits
Initiation visits
Routine monitoring visits
Closeout visits

Data Management

Site Identification and Feasibility Studies
Data entry
CRF review
Query management
Source data verification

Regulatory and Compliance

Regulatory submissions and follow-up
Medical products and devices registration and market entry

Project Management

Support to site and sponsor personnel
Development and maintenance of timelines
Ethics and IRB submissions and follow-up.
Quality assurance and compliance.
Preparation of study SOPs/manuals/guides
Development of project management plans, including clinical monitoring, communication, and training
Oversight of the scope of work and budget with early identification of change orders and monthly forecasting
Overall project coordination and management

Laboratory and Clinical Sites Evaluation

Site identification and set up design and planning.
Site assessment and management.
Site audits

Our Work

• Clinical Trail Management of a phase III, multi-country, randomised, placebo-controlled, double-blinded adaptive platform trial to assess the efficacy and safety of treatments for subjects with monkeypox virus disease. |Nigeria, Democratic Republic of Congo, The Congo, Cameroun, Benin, Sudan, Mali, Ghana, Liberia, Central Republic of Africa | Likak (2023)
• Country representative for products registration with NAFDAC | InTec Products, Inc. (2020-2022).
• Country representative for products registration with NAFDAC | Wondfo Biotech Co. Ltd (2017-2019).